. Multiple alignment of HLA-C allele minimal promoter regions. The nucleotide sequences are listed from -281 to the ATG signal with the psoriasis risk allele HLA-Cw*0602 set as a reference. The cis regulatory elements are highlighted in yellow: the enhancer ĸB (-198 to -186) , the ISRE (-177 to -163) , the w Box (-160 to -155) , the x Box/α site (-138 to -120) , the enhancer B (-101 to -91), the CAAT box (-77 to -73) , and the TATA box (-51 to -46) . Polymorphisms within the regulatory sites are highlighted in purple, deletions are represented by dots whereas homologies by dashes. Table S1 ) which was shown to be less responsive to TNF-α and IFN-γ (see Results, Figures 1-2) . As expected, HLA-C expression levels remained low in the latter samples, despite equal (P21) or even higher (P24) levels of pro-inflammatory cytokines compared to donors P14 and P19. biopsies were taken from the lesional skin of psoriasis (PS) patients who were classified into three groups accoring to their Psoriasis Area and Severity Index (PASI) score: mild PS (PASI < 5), moderate PS (PASI 5-10), and severe PS (PASI > 10). Following RNA extraction and cDNA synthesis, quantitative PCR for HLA-C (a) and HLA-Cw*0602 (b) expression was performed. Data are presented as individual data points with target gene mRNA levels normalized to expression of the internal controls GAPDH (a) and beta-actin (b). One-Way Anova statistical test was performed yielding p values > 0.05 for all panels. c d a b Figure S6 . Effect of treatment on HLA-C expression in psoriatic skin. 5 mm punch biopsies were taken from normal (N) and matched pairs of peri-lesional (PL) and lesional (L) psoriatic skin. Patients were divided into two groups ('untreated + topical' and 'systemic') according to the kind of treatment they were receiving at the time of biopsying (see Table S1 for details). Following RNA extraction and cDNA synthesis, quantitative PCR for HLA-C (a,b) and HLA-Cw*0602 (c,d) was performed. Data are presented as individual data points with target gene mRNA levels normalized to expression of the internal controls GAPDH (a,b) and beta-actin (c,d). One-Way Anova statistical test was performed yielding p values > 0.05 for all panels.
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